文献速递脑血管病

急性颅内动脉粥样硬化相关大血管闭塞血管内治疗的结果

Outcomes of Endovascular Treatment for Acute Intracranial Atherosclerosis-Related Large Vessel Occlusion.
PubMed 文献 · Stroke · 2018-01-01

该回顾性研究纳入318例因大血管闭塞行血管内治疗的急性卒中患者,其中56例(17.6%)为颅内动脉粥样硬化相关大血管闭塞(ICAS(+)-LVO)。ICAS(+)-LVO组再通率80.4%,与ICAS(-)-LVO组88.5%相当(P=0.097);支架取栓再通成功率在ICAS(+)-LVO组为28.9%,低于ICAS(-)-LVO组的93.5%。两组良好预后率(46.4% vs 46.9%)、死亡和症状性颅内出血无显著差异。

要点

  • ICAS(+)-LVO占大血管闭塞血管内治疗患者的17.6%。
  • ICAS(+)-LVO组再通率80.4%,与ICAS(-)-LVO组88.5%相当(P=0.097)。
  • ICAS(+)-LVO组支架取栓再通成功率28.9%,低于ICAS(-)-LVO组的93.5%。

核心结论

  • ICAS(+)-LVO常对机械取栓反应不佳,但采用针对ICAS的特定补救治疗后,其再通率与ICAS(-)-LVO相当,且临床结局无差异。

研究设计与样本

  • 回顾性连续纳入因大血管闭塞行血管内治疗的急性卒中患者,主要依据导管造影将患者分为ICAS(+)-LVO组或ICAS(-)-LVO组,比较两组手术和临床结局。

主要发现

  • 共纳入318例患者,56例(17.6%)为ICAS(+)-LVO。
  • ICAS(+)-LVO组再通45例(80.4%),ICAS(-)-LVO组再通率88.5%(P=0.097)。
  • 支架取栓再通成功率在ICAS(+)-LVO组为28.9%,在ICAS(-)-LVO组为93.5%。
  • ICAS(+)-LVO组剩余患者中84.3%需要针对ICAS的特定补救治疗,包括球囊血管成形术、支架置入和动脉内糖蛋白IIb/IIIa抑制剂输注。
  • 两组良好预后率(46.4% vs 46.9%)、死亡率和症状性颅内出血率无显著差异;糖蛋白IIb/IIIa抑制剂使用与症状性颅内出血无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Endovascular treatment for acute intracranial atherosclerosis-related large vessel occlusion (ICAS [+]-LVO) is one of the challenging issues in modern mechanical thrombectomy era. We evaluated procedural and clinical outcomes of endovascular treatment for the ICAS (+)-LVO. We also compared their outcomes with those of large vessel occlusion not associated with intracranial atherosclerosis (ICAS [-]-LVO). Methods- We retrospectively reviewed consecutive patients with acute stroke who underwent endovascular treatment for LVO. Patients were assigned to the ICAS (+)-LVO group or the ICAS (-)-LVO group primarily based on catheter angiogram. Procedural and clinical outcomes were compared between the ICAS (+)-LVO and ICAS (-)-LVO groups. Results- The present study included 318 patients. Fifty-six patients (17.6%) had an ICAS (+)-LVO. Recanalization was achieved in 45 patients in the ICAS (+)-LVO group (80.4%), which was comparable with the ICAS (-)-LVO group (88.5%; P=0.097). However, recanalization using a stent retriever was less successful in the ICAS (+)-LVO (28.9%) than the ICAS (-)-LVO group (93.5%). Of the remaining patients in the ICAS (+)-LVO group, 84.3% of patients required specific rescue treatments appropriate for ICAS, including balloon angioplasty, stenting, and intra-arterial glycoprotein IIb/IIIa inhibitor infusion. The rates of favorable outcomes (46.4% versus 46.9%), death, and symptomatic intracranial hemorrhage were not significantly different between the 2 groups. Glycoprotein IIb/IIIa inhibitor use was not significantly associated with symptomatic intracranial hemorrhage. Conclusions- ICAS (+)-LVO was often refractory to mechanical thrombectomy. With specific rescue treatments appropriate for ICAS, patients in the ICAS (+)-LVO group had a recanalization rate comparable with patients in the ICAS (-)-LVO. With comparable recanalization rate, the clinical outcomes did not differ between patients with ICAS (+)-LVO and ICAS (-)-LVO.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Baek JH, Kim BM, Heo JH, et al. Outcomes of Endovascular Treatment for Acute Intracranial Atherosclerosis-Related Large Vessel Occlusion. Stroke. 2018. PMID: 30355204. doi:10.1161/STROKEAHA.118.022327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。